| Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape SR Woo, ME Turnis, MV Goldberg, J Bankoti, M Selby, CJ Nirschl, ... Cancer research 72 (4), 917-927, 2012 | 2020 | 2012 |
| R2* magnetic resonance imaging of the liver in patients with iron overload JS Hankins, MB McCarville, RB Loeffler, MP Smeltzer, M Onciu, FA Hoffer, ... Blood, The Journal of the American Society of Hematology 113 (20), 4853-4855, 2009 | 495 | 2009 |
| Distinct TCR signaling pathways drive proliferation and cytokine production in T cells CS Guy, KM Vignali, J Temirov, ML Bettini, AE Overacre, M Smeltzer, ... Nature immunology 14 (3), 262-270, 2013 | 287 | 2013 |
| The International Association for the Study of Lung Cancer global survey on molecular testing in lung cancer MP Smeltzer, MW Wynes, S Lantuejoul, R Soo, SS Ramalingam, ... Journal of Thoracic Oncology 15 (9), 1434-1448, 2020 | 211 | 2020 |
| Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia RE Ware, JM Despotovic, NA Mortier, JM Flanagan, J He, MP Smeltzer, ... Blood, The Journal of the American Society of Hematology 118 (18), 4985-4991, 2011 | 188 | 2011 |
| Glomerular hyperfiltration and albuminuria in children with sickle cell anemia B Aygun, NA Mortier, MP Smeltzer, JS Hankins, RE Ware Pediatric nephrology 26 (8), 1285-1290, 2011 | 176 | 2011 |
| Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma BI Razzouk, SR Rose, S Hongeng, D Wallace, MP Smeltzer, M Zacher, ... Journal of Clinical Oncology 25 (10), 1183-1189, 2007 | 147 | 2007 |
| Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia B Aygun, NA Mortier, MP Smeltzer, BL Shulkin, JS Hankins, RE Ware American journal of hematology 88 (2), 116-119, 2013 | 136 | 2013 |
| Association of pathologic nodal staging quality with survival among patients with non–small cell lung cancer after resection with curative intent MP Smeltzer, NR Faris, MA Ray, RU Osarogiagbon JAMA oncology 4 (1), 80-87, 2018 | 135 | 2018 |
| On the pathogenicity of autoantigen-specific T-cell receptors AR Burton, E Vincent, PY Arnold, GP Lennon, M Smeltzer, CS Li, ... Diabetes 57 (5), 1321-1330, 2008 | 125 | 2008 |
| A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy JH Estepp, MP Smeltzer, G Kang, C Li, WC Wang, C Abrams, B Aygun, ... American journal of hematology 92 (12), 1333-1339, 2017 | 121 | 2017 |
| A transition pilot program for adolescents with sickle cell disease JS Hankins, R Osarogiagbon, P Adams-Graves, L McHugh, V Steele, ... Journal of Pediatric Health Care 26 (6), e45-e49, 2012 | 121 | 2012 |
| Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia MB McCarville, GS Goodin, G Fortner, CS Li, MP Smeltzer, R Adams, ... Pediatric blood & cancer 50 (4), 818-821, 2008 | 95 | 2008 |
| Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload MB McCarville, CM Hillenbrand, RB Loeffler, MP Smeltzer, R Song, CS Li, ... Pediatric radiology 40 (8), 1360-1367, 2010 | 94 | 2010 |
| From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia JS Hankins, B Aygun, K Nottage, C Thornburg, MP Smeltzer, RE Ware, ... Medicine 93 (28), e215, 2014 | 93 | 2014 |
| Sickle Cell Clinical Research and Intervention Program (SCCRIP): a lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood JS Hankins, JH Estepp, JR Hodges, MA Villavicencio, LL Robison, ... Pediatric blood & cancer 65 (9), e27228, 2018 | 90 | 2018 |
| Prevention of conversion to abnormal transcranial D oppler with hydroxyurea in sickle cell anemia: AP hase III international randomized clinical trial JS Hankins, MB McCarville, A Rankine‐Mullings, ME Reid, CLC Lobo, ... American journal of hematology 90 (12), 1099-1105, 2015 | 88 | 2015 |
| Prevalence, prognostic implications, and survival modulators of incompletely resected non–small cell lung cancer in the US national cancer data base RU Osarogiagbon, CC Lin, MP Smeltzer, A Jemal Journal of thoracic oncology 11 (1), e5-e16, 2016 | 84 | 2016 |
| Lung cancer diagnosed through screening, lung nodule, and neither program: a prospective observational study of the detecting early lung cancer (DELUGE) in the Mississippi … RU Osarogiagbon, W Liao, NR Faris, M Meadows-Taylor, C Fehnel, ... Journal of Clinical Oncology 40 (19), 2094-2105, 2022 | 83 | 2022 |
| Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition JS Hankins, MB McCarville, CM Hillenbrand, RB Loeffler, RE Ware, ... Pediatric blood & cancer 55 (3), 495-500, 2010 | 81 | 2010 |
